Human Albumin Administration in Subarachnoid Hemorrhage: Results of an International Survey View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-12-31

AUTHORS

Jose I. Suarez, Renee H. Martin, Eusebia Calvillo, David Zygun, Oliver Flower, George K. Wong, Eric M. Bershad, Chethan P. Venkatasubba Rao, Alexandros Georgiadis, Draga Jichici, Peter D. Leroux

ABSTRACT

BackgroundSubarachnoid hemorrhage (SAH) is a devastating disease. Nimodipine is the only medical treatment shown to improve outcome of SAH patients. Human albumin (ALB) may exert neuroprotection in SAH. However, current usage of ALB in SAH is not known. We conducted an international survey of clinicians involved in the care of SAH patients to determine current practice of ALB administration in SAH.MethodsWe constructed a 27-question survey. Our sampling frame consisted of neurointensivists, general intensivists, neurocritical care nurses, critical care pharmacists, and neurosurgeons. The survey was available from 11/15/2012 to 12/15/2012. We performed mostly descriptive statistical analysis.ResultsWe obtained 362 responses from a diverse range of world regions. Most respondents were intensivist physicians (88 %), who worked in academic institutions (73.5 %) with a bed capacity >500 (64.1 %) and an established institutional management protocol for SAH patients (70.2 %). Most respondents (83.5 %) indicated that their institutions do not incorporate ALB in their protocol, but half of them (45.9 %) indicated using ALB outside it. ALB administration is influenced by several factors: geographic variation (more common among US respondents); institutions with a dedicated neuroICU; and availability of SAH management protocol. Most respondents (75 %) indicated that a clinical trial to test the efficacy of ALB in SAH is needed.ConclusionsIn this survey we found that ALB administration in SAH patients is common and influenced by several factors. Majority of respondents support a randomized clinical trial to determine the safety and efficacy of ALB administration in SAH patients. More... »

PAGES

277-286

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12028-013-9942-y

DOI

http://dx.doi.org/10.1007/s12028-013-9942-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038800751

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24378920


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Critical Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Surveys", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroprotective Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum Albumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum Albumin, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Subarachnoid Hemorrhage", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suarez", 
        "givenName": "Jose I.", 
        "id": "sg:person.01231175755.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231175755.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA", 
          "id": "http://www.grid.ac/institutes/grid.259828.c", 
          "name": [
            "Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martin", 
        "givenName": "Renee H.", 
        "id": "sg:person.0616044347.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616044347.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calvillo", 
        "givenName": "Eusebia", 
        "id": "sg:person.01173020607.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173020607.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AL, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17089.37", 
          "name": [
            "Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AL, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zygun", 
        "givenName": "David", 
        "id": "sg:person.01106532316.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106532316.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Intensive Care, North Shore Hospital, University of Sydney, Sydney, SW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "Division of Intensive Care, North Shore Hospital, University of Sydney, Sydney, SW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Flower", 
        "givenName": "Oliver", 
        "id": "sg:person.01302161452.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302161452.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.10784.3a", 
          "name": [
            "Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wong", 
        "givenName": "George K.", 
        "id": "sg:person.07666513672.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07666513672.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bershad", 
        "givenName": "Eric M.", 
        "id": "sg:person.01032002646.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032002646.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Venkatasubba Rao", 
        "givenName": "Chethan P.", 
        "id": "sg:person.01174650012.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174650012.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Georgiadis", 
        "givenName": "Alexandros", 
        "id": "sg:person.0642154733.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642154733.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology and Critical Care Medicine, McMaster University, Hamilton, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Neurology and Critical Care Medicine, McMaster University, Hamilton, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jichici", 
        "givenName": "Draga", 
        "id": "sg:person.0675014665.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675014665.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.265008.9", 
          "name": [
            "Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leroux", 
        "givenName": "Peter D.", 
        "id": "sg:person.01155410256.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155410256.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12028-011-9605-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046372375", 
          "https://doi.org/10.1007/s12028-011-9605-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12028-010-9392-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018828666", 
          "https://doi.org/10.1007/s12028-010-9392-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc9977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032796563", 
          "https://doi.org/10.1186/cc9977"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12-31", 
    "datePublishedReg": "2013-12-31", 
    "description": "BackgroundSubarachnoid hemorrhage (SAH) is a devastating disease. Nimodipine is the only medical treatment shown to improve outcome of SAH patients. Human albumin (ALB) may exert neuroprotection in SAH. However, current usage of ALB in SAH is not known. We conducted an international survey of clinicians involved in the care of SAH patients to determine current practice of ALB administration in SAH.MethodsWe constructed a 27-question survey. Our sampling frame consisted of neurointensivists, general intensivists, neurocritical care nurses, critical care pharmacists, and neurosurgeons. The survey was available from 11/15/2012 to 12/15/2012. We performed mostly descriptive statistical analysis.ResultsWe obtained 362 responses from a diverse range of world regions. Most respondents were intensivist physicians (88\u00a0%), who worked in academic institutions (73.5\u00a0%) with a bed capacity >500 (64.1\u00a0%) and an established institutional management protocol for SAH patients (70.2\u00a0%). Most respondents (83.5\u00a0%) indicated that their institutions do not incorporate ALB in their protocol, but half of them (45.9\u00a0%) indicated using ALB outside it. ALB administration is influenced by several factors: geographic variation (more common among US respondents); institutions with a dedicated neuroICU; and availability of SAH management protocol. Most respondents (75\u00a0%) indicated that a clinical trial to test the efficacy of ALB in SAH is needed.ConclusionsIn this survey we found that ALB administration in SAH patients is common and influenced by several factors. Majority of respondents support a randomized clinical trial to determine the safety and efficacy of ALB administration in SAH patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12028-013-9942-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1031461", 
        "issn": [
          "1541-6933", 
          "1556-0961"
        ], 
        "name": "Neurocritical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "Alb administration", 
      "SAH patients", 
      "clinical trials", 
      "only medical treatment", 
      "neurocritical care nurses", 
      "critical care pharmacists", 
      "institutional management protocol", 
      "efficacy of albumin", 
      "human albumin administration", 
      "Most respondents", 
      "randomized clinical trials", 
      "management protocol", 
      "BackgroundSubarachnoid hemorrhage", 
      "general intensivists", 
      "albumin administration", 
      "subarachnoid hemorrhage", 
      "care nurses", 
      "care pharmacists", 
      "intensivist physicians", 
      "medical treatment", 
      "patients", 
      "majority of respondents", 
      "administration", 
      "international survey", 
      "human albumin", 
      "SAH", 
      "hemorrhage", 
      "devastating disease", 
      "bed capacity", 
      "descriptive statistical analysis", 
      "trials", 
      "albumin", 
      "efficacy", 
      "sampling frame", 
      "current practice", 
      "NeuroICU", 
      "neuroprotection", 
      "neurointensivists", 
      "intensivists", 
      "respondents", 
      "nimodipine", 
      "statistical analysis", 
      "clinicians", 
      "MethodsWe", 
      "nurses", 
      "disease", 
      "pharmacists", 
      "physicians", 
      "neurosurgeons", 
      "care", 
      "protocol", 
      "outcomes", 
      "ConclusionsIn", 
      "treatment", 
      "factors", 
      "survey", 
      "geographic variation", 
      "academic institutions", 
      "safety", 
      "majority", 
      "ResultsWe", 
      "institutions", 
      "response", 
      "half", 
      "current usage", 
      "world regions", 
      "diverse range", 
      "practice", 
      "analysis", 
      "results", 
      "capacity", 
      "availability", 
      "region", 
      "usage", 
      "variation", 
      "range", 
      "frame", 
      "dedicated neuroICU", 
      "SAH management protocol"
    ], 
    "name": "Human Albumin Administration in Subarachnoid Hemorrhage: Results of an International Survey", 
    "pagination": "277-286", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038800751"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12028-013-9942-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24378920"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12028-013-9942-y", 
      "https://app.dimensions.ai/details/publication/pub.1038800751"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_600.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12028-013-9942-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12028-013-9942-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12028-013-9942-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12028-013-9942-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12028-013-9942-y'


 

This table displays all metadata directly associated to this object as RDF triples.

285 TRIPLES      22 PREDICATES      119 URIs      108 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12028-013-9942-y schema:about N01ecd8a6b6f847d0a68673c5b5bf3de0
2 N040e764d2bc64aeb87140cbdd7f426ff
3 N1cc3eeeb2dfe4c29a1684c5e4179a561
4 N1de2a637d1694c119e3b48d34178fee7
5 N69f12ab2a52f4c49a4424659c2178e36
6 N7a3fa9a8868f42bd8dec057a9c089927
7 N8f171b7456964e86bbf0eb5c581f55ab
8 Naf9fa48e32674e46a4dde911270473d1
9 Nc525dec5fb0f43649d6ba925d2d7d914
10 Nea46eec175dd408095fc7e3dd9c87295
11 Nf7c181efc2a94df784732ce9689cb412
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N0857efc67fd949ed9e5669b20e5f4a2f
15 schema:citation sg:pub.10.1007/s12028-010-9392-8
16 sg:pub.10.1007/s12028-011-9605-9
17 sg:pub.10.1186/cc9977
18 schema:datePublished 2013-12-31
19 schema:datePublishedReg 2013-12-31
20 schema:description BackgroundSubarachnoid hemorrhage (SAH) is a devastating disease. Nimodipine is the only medical treatment shown to improve outcome of SAH patients. Human albumin (ALB) may exert neuroprotection in SAH. However, current usage of ALB in SAH is not known. We conducted an international survey of clinicians involved in the care of SAH patients to determine current practice of ALB administration in SAH.MethodsWe constructed a 27-question survey. Our sampling frame consisted of neurointensivists, general intensivists, neurocritical care nurses, critical care pharmacists, and neurosurgeons. The survey was available from 11/15/2012 to 12/15/2012. We performed mostly descriptive statistical analysis.ResultsWe obtained 362 responses from a diverse range of world regions. Most respondents were intensivist physicians (88 %), who worked in academic institutions (73.5 %) with a bed capacity >500 (64.1 %) and an established institutional management protocol for SAH patients (70.2 %). Most respondents (83.5 %) indicated that their institutions do not incorporate ALB in their protocol, but half of them (45.9 %) indicated using ALB outside it. ALB administration is influenced by several factors: geographic variation (more common among US respondents); institutions with a dedicated neuroICU; and availability of SAH management protocol. Most respondents (75 %) indicated that a clinical trial to test the efficacy of ALB in SAH is needed.ConclusionsIn this survey we found that ALB administration in SAH patients is common and influenced by several factors. Majority of respondents support a randomized clinical trial to determine the safety and efficacy of ALB administration in SAH patients.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N3db4212d923e4ce8aaf125392d036151
25 N7fade09531ba4daa86147e5b9f426656
26 sg:journal.1031461
27 schema:keywords Alb administration
28 BackgroundSubarachnoid hemorrhage
29 ConclusionsIn
30 MethodsWe
31 Most respondents
32 NeuroICU
33 ResultsWe
34 SAH
35 SAH management protocol
36 SAH patients
37 academic institutions
38 administration
39 albumin
40 albumin administration
41 analysis
42 availability
43 bed capacity
44 capacity
45 care
46 care nurses
47 care pharmacists
48 clinical trials
49 clinicians
50 critical care pharmacists
51 current practice
52 current usage
53 dedicated neuroICU
54 descriptive statistical analysis
55 devastating disease
56 disease
57 diverse range
58 efficacy
59 efficacy of albumin
60 factors
61 frame
62 general intensivists
63 geographic variation
64 half
65 hemorrhage
66 human albumin
67 human albumin administration
68 institutional management protocol
69 institutions
70 intensivist physicians
71 intensivists
72 international survey
73 majority
74 majority of respondents
75 management protocol
76 medical treatment
77 neurocritical care nurses
78 neurointensivists
79 neuroprotection
80 neurosurgeons
81 nimodipine
82 nurses
83 only medical treatment
84 outcomes
85 patients
86 pharmacists
87 physicians
88 practice
89 protocol
90 randomized clinical trials
91 range
92 region
93 respondents
94 response
95 results
96 safety
97 sampling frame
98 statistical analysis
99 subarachnoid hemorrhage
100 survey
101 treatment
102 trials
103 usage
104 variation
105 world regions
106 schema:name Human Albumin Administration in Subarachnoid Hemorrhage: Results of an International Survey
107 schema:pagination 277-286
108 schema:productId N4b92f77c75d443aba232de0fdea54822
109 N81000fb58d2649d18de612667641eb8f
110 N90371909ede7458f9d5d366a92d95aef
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038800751
112 https://doi.org/10.1007/s12028-013-9942-y
113 schema:sdDatePublished 2021-11-01T18:20
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher Nad690bb9cc424fc99ea2bbac3f25a230
116 schema:url https://doi.org/10.1007/s12028-013-9942-y
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N01ecd8a6b6f847d0a68673c5b5bf3de0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 N02d8505e8de843f78dd8ed0f350e19cc rdf:first sg:person.0616044347.50
124 rdf:rest Ndbe00918cf13410dafe3314a8a0b2289
125 N040e764d2bc64aeb87140cbdd7f426ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Serum Albumin, Human
127 rdf:type schema:DefinedTerm
128 N0538ba3a766e407bb612bd04a6ba9325 rdf:first sg:person.01155410256.20
129 rdf:rest rdf:nil
130 N0857efc67fd949ed9e5669b20e5f4a2f rdf:first sg:person.01231175755.82
131 rdf:rest N02d8505e8de843f78dd8ed0f350e19cc
132 N08fc245a136446ee87b07d750b8f59a1 rdf:first sg:person.0675014665.82
133 rdf:rest N0538ba3a766e407bb612bd04a6ba9325
134 N1cc3eeeb2dfe4c29a1684c5e4179a561 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Neuroprotective Agents
136 rdf:type schema:DefinedTerm
137 N1de2a637d1694c119e3b48d34178fee7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Critical Care
139 rdf:type schema:DefinedTerm
140 N2123601d2867478987aece22d8993fd4 rdf:first sg:person.01106532316.03
141 rdf:rest Nf0cf527dc7bc487b96a5eb4779c506ac
142 N2950f3a0ce604816a995a46e8724d24a rdf:first sg:person.0642154733.47
143 rdf:rest N08fc245a136446ee87b07d750b8f59a1
144 N3db4212d923e4ce8aaf125392d036151 schema:issueNumber 2
145 rdf:type schema:PublicationIssue
146 N4b92f77c75d443aba232de0fdea54822 schema:name pubmed_id
147 schema:value 24378920
148 rdf:type schema:PropertyValue
149 N69f12ab2a52f4c49a4424659c2178e36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Neurology
151 rdf:type schema:DefinedTerm
152 N6f21d91521fb4894afd46428aebe11bc rdf:first sg:person.07666513672.96
153 rdf:rest Nd69b9b9bd9924a2884fcfbc35d5744df
154 N7a3fa9a8868f42bd8dec057a9c089927 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Serum Albumin
156 rdf:type schema:DefinedTerm
157 N7fade09531ba4daa86147e5b9f426656 schema:volumeNumber 20
158 rdf:type schema:PublicationVolume
159 N81000fb58d2649d18de612667641eb8f schema:name doi
160 schema:value 10.1007/s12028-013-9942-y
161 rdf:type schema:PropertyValue
162 N8f171b7456964e86bbf0eb5c581f55ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Clinical Protocols
164 rdf:type schema:DefinedTerm
165 N90371909ede7458f9d5d366a92d95aef schema:name dimensions_id
166 schema:value pub.1038800751
167 rdf:type schema:PropertyValue
168 Nad690bb9cc424fc99ea2bbac3f25a230 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 Naf9fa48e32674e46a4dde911270473d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Practice Patterns, Physicians'
172 rdf:type schema:DefinedTerm
173 Nc525dec5fb0f43649d6ba925d2d7d914 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Health Care Surveys
175 rdf:type schema:DefinedTerm
176 Nd69b9b9bd9924a2884fcfbc35d5744df rdf:first sg:person.01032002646.44
177 rdf:rest Nfd8a33f551784828b293ec10c38c8081
178 Ndbe00918cf13410dafe3314a8a0b2289 rdf:first sg:person.01173020607.90
179 rdf:rest N2123601d2867478987aece22d8993fd4
180 Nea46eec175dd408095fc7e3dd9c87295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Adult
182 rdf:type schema:DefinedTerm
183 Nf0cf527dc7bc487b96a5eb4779c506ac rdf:first sg:person.01302161452.38
184 rdf:rest N6f21d91521fb4894afd46428aebe11bc
185 Nf7c181efc2a94df784732ce9689cb412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Subarachnoid Hemorrhage
187 rdf:type schema:DefinedTerm
188 Nfd8a33f551784828b293ec10c38c8081 rdf:first sg:person.01174650012.43
189 rdf:rest N2950f3a0ce604816a995a46e8724d24a
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
194 schema:name Clinical Sciences
195 rdf:type schema:DefinedTerm
196 sg:journal.1031461 schema:issn 1541-6933
197 1556-0961
198 schema:name Neurocritical Care
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01032002646.44 schema:affiliation grid-institutes:grid.39382.33
202 schema:familyName Bershad
203 schema:givenName Eric M.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032002646.44
205 rdf:type schema:Person
206 sg:person.01106532316.03 schema:affiliation grid-institutes:grid.17089.37
207 schema:familyName Zygun
208 schema:givenName David
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106532316.03
210 rdf:type schema:Person
211 sg:person.01155410256.20 schema:affiliation grid-institutes:grid.265008.9
212 schema:familyName Leroux
213 schema:givenName Peter D.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155410256.20
215 rdf:type schema:Person
216 sg:person.01173020607.90 schema:affiliation grid-institutes:grid.39382.33
217 schema:familyName Calvillo
218 schema:givenName Eusebia
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173020607.90
220 rdf:type schema:Person
221 sg:person.01174650012.43 schema:affiliation grid-institutes:grid.39382.33
222 schema:familyName Venkatasubba Rao
223 schema:givenName Chethan P.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174650012.43
225 rdf:type schema:Person
226 sg:person.01231175755.82 schema:affiliation grid-institutes:grid.39382.33
227 schema:familyName Suarez
228 schema:givenName Jose I.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231175755.82
230 rdf:type schema:Person
231 sg:person.01302161452.38 schema:affiliation grid-institutes:grid.1013.3
232 schema:familyName Flower
233 schema:givenName Oliver
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302161452.38
235 rdf:type schema:Person
236 sg:person.0616044347.50 schema:affiliation grid-institutes:grid.259828.c
237 schema:familyName Martin
238 schema:givenName Renee H.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616044347.50
240 rdf:type schema:Person
241 sg:person.0642154733.47 schema:affiliation grid-institutes:grid.39382.33
242 schema:familyName Georgiadis
243 schema:givenName Alexandros
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642154733.47
245 rdf:type schema:Person
246 sg:person.0675014665.82 schema:affiliation grid-institutes:grid.25073.33
247 schema:familyName Jichici
248 schema:givenName Draga
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675014665.82
250 rdf:type schema:Person
251 sg:person.07666513672.96 schema:affiliation grid-institutes:grid.10784.3a
252 schema:familyName Wong
253 schema:givenName George K.
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07666513672.96
255 rdf:type schema:Person
256 sg:pub.10.1007/s12028-010-9392-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018828666
257 https://doi.org/10.1007/s12028-010-9392-8
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s12028-011-9605-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046372375
260 https://doi.org/10.1007/s12028-011-9605-9
261 rdf:type schema:CreativeWork
262 sg:pub.10.1186/cc9977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032796563
263 https://doi.org/10.1186/cc9977
264 rdf:type schema:CreativeWork
265 grid-institutes:grid.1013.3 schema:alternateName Division of Intensive Care, North Shore Hospital, University of Sydney, Sydney, SW, Australia
266 schema:name Division of Intensive Care, North Shore Hospital, University of Sydney, Sydney, SW, Australia
267 rdf:type schema:Organization
268 grid-institutes:grid.10784.3a schema:alternateName Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China
269 schema:name Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China
270 rdf:type schema:Organization
271 grid-institutes:grid.17089.37 schema:alternateName Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AL, Canada
272 schema:name Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AL, Canada
273 rdf:type schema:Organization
274 grid-institutes:grid.25073.33 schema:alternateName Department of Neurology and Critical Care Medicine, McMaster University, Hamilton, ON, Canada
275 schema:name Department of Neurology and Critical Care Medicine, McMaster University, Hamilton, ON, Canada
276 rdf:type schema:Organization
277 grid-institutes:grid.259828.c schema:alternateName Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA
278 schema:name Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA
279 rdf:type schema:Organization
280 grid-institutes:grid.265008.9 schema:alternateName Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA
281 schema:name Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA
282 rdf:type schema:Organization
283 grid-institutes:grid.39382.33 schema:alternateName Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA
284 schema:name Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB:320, 77030, Houston, TX, USA
285 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...